CNS inflammatory demyelinating disorders: MS, NMOSD and MOG antibody associated disease

Area of Science:

• Neuroimmunology
• Neurology
• Inflammatory Disorders

Background:

• Multiple Sclerosis (MS) is the most common central nervous system (CNS) inflammatory demyelinating disorder.
• Neuromyelitis Optica Spectrum Disorder (NMOSD) and myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease are less common CNS inflammatory disorders.
• These conditions share clinical characteristics like optic neuritis and myelitis, complicating diagnosis.

Purpose of the Study:

• To review the clinical presentation, diagnosis, and natural history of MS, NMOSD, and MOG antibody-associated disease.
• To highlight the importance of distinguishing between these CNS inflammatory disorders due to differing prognoses and management strategies.
• To emphasize the role of clinical indicators, history, neurological examination, imaging, and cerebrospinal fluid analysis in accurate diagnosis.

Main Methods:

• Review of clinical presentations of CNS inflammatory demyelinating disorders.
• Analysis of diagnostic challenges and considerations for MS, NMOSD, and MOG antibody-associated disease.
• Examination of the impact of serological testing (anti-aquaporin-4 and anti-MOG antibodies) on diagnosis.

Main Results:

• While MS is most common, NMOSD and MOG-AD present with overlapping symptoms, making differentiation difficult.
• Reliable antibody testing has improved diagnosis, but seronegative cases remain challenging.
• Clinical features, history, examination, imaging, and CSF analysis are vital for accurate diagnosis.

Conclusions:

• Accurate diagnosis of CNS inflammatory demyelinating disorders, including MS, NMOSD, and MOG-AD, is critical.
• Distinguishing these conditions is essential due to differences in clinical phenotypes, prognosis, and treatment.
• A comprehensive diagnostic approach integrating clinical, imaging, and serological data is necessary.